Concepedia

Author

Kenneth E. Lipson

FibroGen (United States)ORCID

Also Known As

K E Lipson, K LIPSON, K Lipson, K. E. LIPSON, K. E. Lipson, K. Lipson, K.E Lipson, K.E. Lipson, KENNETH E. LIPSON, Kenneth E Lipson

156

Publications

7.6K

Citations

51

H-Index

131

Concepts

All Affiliations

FibroGen (United States)German Cancer Research CenterHeidelberg UniversityTemple UniversityUniversity Hospital Heidelberg
KE

About

Kenneth E. Lipson is an author at FibroGen (United States) specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

32

39

3.8K

2

Natural Sciences

10

10

547

3

Health Sciences

6

6

516

4

Biochemistry

4

4

154

5

Allergy

2

2

30

Kenneth E. Lipson

×

90

Publications

7.3K

Citations

50

H-Index

YearCitations

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

Kenneth E. Lipson, Carol Wong, Yuchin Teng,

Fibrogenesis & Tissue Repair

2012

559

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.

James G. Christensen, Randall Schreck, Jon Burrows,

PubMed

2003

497

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis

Amir Abdollahi, Minglun Li, Ping Gong,

The Journal of Experimental Medicine

2005

380

Towards Better Definition, Quantification and Treatment of Fibrosis in Heart Failure. A Scientific Roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

Rudolf A. de Boer, Gilles W. De Keulenaer, Johann Bauersachs,

European Journal of Heart Failure

2019

277

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

Amir Abdollahi, David W. Griggs, Heike Zieher,

Clinical Cancer Research

2005

204

Trimodal Cancer Treatment: Beneficial Effects of Combined Antiangiogenesis, Radiation, and Chemotherapy

Peter E. Huber, Marc Bischof, Jürgen Jenne,

Cancer Research

2005

184

The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants

Sylvie Berthou, Daniel M. Aebersold, Laura S. Schmidt,

Oncogene

2004

178

Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.

Amir Abdollahi, Kenneth E. Lipson, Axel Sckell,

PubMed

2003

159

Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis

Sebastian Bickelhaupt, Christian Erbel, Carmen Timke,

JNCI Journal of the National Cancer Institute

2016

150

SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.

Amir Abdollahi, Kenneth E. Lipson, Xiaohong Han,

PubMed

2003

149

Page 1